14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 15, 2024 Buy 250 000 Huemoeller John Walter Ii Convertible Note
Mar 15, 2024 Buy 7 837 500 Valencia Catalina Convertible Note
Mar 15, 2024 Buy 35 000 Schroeder Blake Convertible Note
Mar 15, 2024 Buy 35 000 Cunningham Robert L Convertible Note
Mar 15, 2024 Buy 35 000 Scott Timothy Richard Convertible Note
Mar 15, 2024 Buy 35 000 O'rourke Peter Convertible Note
Mar 15, 2024 Buy 53 500 Malasek Robert Convertible Note
Mar 15, 2024 Buy 1 Huemoeller John Walter Ii Convertible Note
May 23, 2023 Buy 2 000 000 Phinney Kurt Option
Sep 23, 2022 Buy 1 000 000 Schroeder Blake Option
Sep 23, 2022 Buy 500 000 Malasek Robert Option
Sep 23, 2022 Buy 1 000 000 Cunningham Robert L Option
Sep 23, 2022 Buy 1 000 000 Scott Timothy Richard Option
Sep 23, 2022 Buy 5 000 000 Huemoeller John Walter Ii Option
Aug 29, 2022 Buy 3 861 004 Valencia Catalina Common Stock
Aug 22, 2022 Buy 854 012 Schroeder Blake Common Stock
Feb 10, 2022 Buy 25 000 Schroeder Blake Convertible Note (Convertible into Common Stock)
May 06, 2021 Sell 2 000 000 Huemoeller John Walter Ii Option
Dec 10, 2020 Buy 300 000 Malasek Robert Option
Dec 10, 2020 Buy 3 000 000 Huemoeller John Walter Ii Option
May 13, 2020 Buy 500 000 Cunningham Robert L Option
May 13, 2020 Buy 500 000 Scott Timothy Richard Option
Mar 19, 2020 Buy 6 000 000 Huemoeller John Walter Ii Common Stock
Mar 19, 2020 Buy 0 Glycodots, Llc Common Stock
Mar 19, 2020 Buy 0 Valencia Catalina Common Stock
Jan 02, 2019 Buy 2 000 000 Huemoeller John Walter Ii Option
Mar 21, 2018 Buy 50 000 Malasek Robert Common Stock
May 18, 2017 Buy 0 Schroeder Blake Common Stock
May 18, 2017 Buy 0 Schroeder Blake Preferred Stock
May 18, 2017 Buy 0 Scott Timothy Richard Common Stock
May 18, 2017 Buy 0 Scott Timothy Richard Preferred Stock
May 18, 2017 Buy 0 Huemoeller John Walter Ii Common Stock
May 18, 2017 Buy 0 Huemoeller John Walter Ii Preferred Stock
May 18, 2017 Buy 0 Cunningham Robert L Common Stock
May 18, 2017 Buy 0 Cunningham Robert L Preferred Stock
Dec 31, 2016 Buy 0 Medical Marijuana Inc
Dec 31, 2016 Buy 0 Medical Marijuana Inc
Dec 31, 2016 Buy 0 Changoer Lekhram
Dec 31, 2016 Buy 0 Anastassov George
Jun 29, 2016 Buy 0 Malasek Robert Common Stock
Jun 29, 2016 Buy 0 Malasek Robert Preferred Stock
Feb 05, 2016 Buy 125 000 Anastassov George Common Stock
Dec 18, 2015 Buy 25 000 Changoer Lekhram Common Stock
Nov 09, 2015 Buy 125 000 Anastassov George Common Stock
Apr 23, 2015 Buy 1 000 000 Changoer Lekhram Preferred Stock
Apr 23, 2015 Buy 1 000 000 Anastassov George Preferred Stock
Feb 23, 2015 Buy 2 000 Anastassov George Common Stock
Mar 21, 2014 Sell 20 000 000 Samuels Rosemary COMMON STOCK
Mar 21, 2014 Sell 1 000 000 Samuels Rosemary PREFERRED STOCK
Mar 21, 2014 Buy 0 Medical Marijuana, Inc. Common Stock
Mar 21, 2014 Buy 0 Medical Marijuana, Inc. Preferred Stock
Mar 21, 2014 Buy 0 Changoer Lekhram Common Stock
Mar 21, 2014 Buy 0 Changoer Lekhram Preferred Stock
Mar 21, 2014 Buy 0 Van Damme Philip A Common Stock
Mar 21, 2014 Buy 0 Van Damme Philip A Preferred Stock
Mar 21, 2014 Buy 0 Sanammad Foundation Common Stock
Mar 21, 2014 Buy 0 Sanammad Foundation Preferred Stock
Mar 20, 2014 Buy 0 Anastassov George Common Stock
Mar 20, 2014 Buy 0 Anastassov George Preferred Stock
Dec 31, 2013 Sell 0 Samuels Rosemary COMMON STOCK
Dec 31, 2013 Sell 0 Samuels Rosemary PREFERRED STOCK
Dec 31, 2012 Sell 0 Samuels Rosemary COMMON STOCK
Dec 31, 2012 Sell 0 Samuels Rosemary PREFERRED STOCK
Dec 31, 2011 Sell 0 Samuels Rosemary COMMON STOCK
Dec 31, 2011 Sell 0 Samuels Rosemary PREFERRED STOCK
Jul 12, 2011 Buy 0 Samuels Rosemary COMMON STOCK
Jul 12, 2011 Buy 0 Samuels Rosemary PREFERRED STOCK
INSIDER POWER
93.221
Last 67 transactions
Buy: 38 148 017 | Sell: 23 000 000 (Shares)

Based on the 67 latest insides trades, we have calculated the insider power to be positive at a ratio of 93.221.

In total, the insiders bought 38 148 017 and sold 23 000 000 AXIM shares in the last 67 trades.

Click to get the best stock tips daily for free!

About AXIM Biotechnologies, Inc.

AXIM Biotechnologies. AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for managem... AXIM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT